NCT06277843

Brief Summary

Globally, over 15 million neonates are born preterm each year. They account for approximately 30% of global neonatal deaths and 19% of total neonatal deaths in Bangladesh. They usually die because they cannot maintain normal temperature due to their weight, immature skin and underdeveloped thermal regulatory capacity of the brain. Maintaining continuous KMC for at least 16-20 hours/day, is sometimes not feasible for mothers or caregivers. In addition, we also have the challenge of keeping preterm or LBW neonates warm during transportation. The scientists at icddr,b, Johns Hopkins University, and George Mason University developed the re-usable thermal jacket for keeping preterm or low-birth-weight neonate warm. We propose to build on previous work by systematically testing the safety of the 'thermal jacket' among preterm or low birthweight (LBW) neonates. Objective of this study is to conduct clinical safety trial of the thermal jacket to test whether the thermal jacket can retain euthermia of preterm or LBW neonates for 2 hours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for early_phase_1

Timeline
Completed

Started Jun 2022

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 13, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 26, 2024

Completed
Last Updated

February 26, 2024

Status Verified

February 1, 2024

Enrollment Period

3 months

First QC Date

February 19, 2024

Last Update Submit

February 19, 2024

Conditions

Keywords

Preterm neonateLow birthweight neonateKangaroo Mother CareThermal JacketSafety Trial

Outcome Measures

Primary Outcomes (1)

  • Body temperature of preterm or low birthweight neonates and duration of time in euthermic range.

    Percentage of events maintained the body temperature in euthermic range among the enrolled preterm or low birthweight neonates.

    2 hours per event

Study Arms (1)

Thermal Jacket

EXPERIMENTAL
Device: Thermal Jacket

Interventions

In the intervention group, the enrolled preterm or low birthweight eligible neonates gets the intervention (Thermal Jacket) as a supplement of Kangaroo Mother Care (KMC).

Thermal Jacket

Eligibility Criteria

Age0 Hours - 72 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Neonate aged between 0-72 hours
  • Birthweight between 1800g to 2000g
  • No gross congenital anomaly
  • Normal heart 100-160 per minute
  • Capillary Refill Time ≤3 sec
  • Respiratory rate 30-59 per minute
  • Breaths comfortably (no chest indrawing, No gasping)
  • No sign of respiratory distress (respiratory rate within normal limit)
  • Pink in room air (without oxygen therapy)
  • H/O No prolonged or frequent apnea \& no visible apnea during study enrolment
  • No major surgical problem

You may not qualify if:

  • In nasogastric tube
  • In oxygen therapy
  • In intravenous fluid

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bangabandhu Sheikh Mujib Medical University (BSMMU)

Dhaka, 1000, Bangladesh

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Anisuddin Ahmed, MS

    International Centre for Diarrhoeal Disease Research, Bangladesh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single arm non-randomized trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2024

First Posted

February 26, 2024

Study Start

June 13, 2022

Primary Completion

September 1, 2022

Study Completion

September 30, 2022

Last Updated

February 26, 2024

Record last verified: 2024-02

Locations